{"disease":{"id":"abuse-potential","name":"abuse potential"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05106153","title":"A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT06247488","title":"Abuse Potential of HORIZANT With and Without Oxycodone in Healthy, Nondependent Recreational Opioid Users","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Arbor Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06097676","title":"An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Arbor Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03799900","title":"Assessment of Abuse Potential of Rapastinel in Humans","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Naurex, Inc, an affiliate of Allergan plc","has_results":false},{"nct_id":"NCT05053126","title":"Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Viatris Specialty LLC","has_results":true},{"nct_id":"NCT05319756","title":"Study Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Viatris Specialty LLC","has_results":true},{"nct_id":"NCT04570436","title":"Evaluating the Abuse Potential of NEURONTIN® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Viatris Specialty LLC","has_results":true},{"nct_id":"NCT05256108","title":"Assessment of Abuse Potential of Cebranopadol in Humans","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Tris Pharma, Inc.","has_results":false},{"nct_id":"NCT03200080","title":"A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"Biotie Therapies Inc.","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}